Journey Medical Corp (DERM)
3.58
-0.04
(-1.10%)
USD |
NASDAQ |
May 01, 16:00
3.58
0.00 (0.00%)
After-Hours: 16:12
Journey Medical Cash from Financing (Quarterly): 19.21M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 19.21M |
| September 30, 2023 | -10.98M |
| June 30, 2023 | -13.09M |
| March 31, 2023 | 0.052M |
| December 31, 2022 | 0.948M |
| September 30, 2022 | 4.031M |
| Date | Value |
|---|---|
| June 30, 2022 | 0.111M |
| March 31, 2022 | 11.37M |
| December 31, 2021 | 31.80M |
| September 30, 2021 | 11.21M |
| June 30, 2021 | 0.616M |
| March 31, 2021 | 9.391M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-13.09M
Minimum
Jun 2023
31.80M
Maximum
Dec 2021
5.389M
Average
2.490M
Median
Cash from Financing (Quarterly) Benchmarks
| Fortress Biotech Inc | 43.62M |
| Puma Biotechnology Inc | 0.00 |
| GT Biopharma Inc | 0.00 |
| FibroGen Inc | -0.246M |
| Outlook Therapeutics Inc | -0.0032M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -16.52M |
| Free Cash Flow | 0.24M |
| Free Cash Flow Per Share (Quarterly) | -0.8549 |
| Free Cash Flow to Equity (Quarterly) | -31.14M |
| Free Cash Flow to Firm (Quarterly) | -16.52M |
| Free Cash Flow Yield | 0.35% |